Phase II/III therapeutic trial to study the safety and efficacy of the novel application of an FDA-approved drug to reduce neurotoxin levels and improve neurologic outcome in SAH patients

  • Hwang, Brian (PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/09 → 1/1/10

Funding

  • Doris Duke Charitable Foundation

ASJC Scopus Subject Areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)
  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)